foto

MD PhD A. Wolkerstorfer

Position
Medical Specialist
Main activities
Patient care, Research
Specialisation
dermatology
Focus of research
Laserdermatology: clinical research on laser treatments; development of innovative treatments

Pigment disorders: clinical research, research on pigmentcell transplantation

Key publications
  • Kroon Marije W., Wind Bas S., Beek Johan F., van der Veen J. P. Wietze, Nieuweboer-Krobotová Ludmila, Bos Jan D., Wolkerstorfer Albert Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled pilot study Journal of the American Academy of Dermatology 2011;64 (3):516-523 [PubMed]
  • Wind Bas S., Kroon Marije W., Meesters Arne A., Beek Johan F., van der Veen J. P. Wietze, Nieuweboer-Krobotová Ludmila, Bos Jan D., Wolkerstorfer Albert Non-Ablative 1,550 nm Fractional Laser Therapy Versus Triple Topical Therapy for the Treatment of Melasma: A Randomized Controlled Split-Face Study Lasers in surgery and medicine 2010;42 (7):607-612 [PubMed]
  • Brenninkmeijer E. E. A., Spuls P. I., Lindeboom R., van der Wal A. C., Bos J. D., Wolkerstorfer A. Excimer laser vs. clobetasol propionate 0·05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot British journal of dermatology 2010;163 (4):823-831 [PubMed]
  • van Drooge Anne Margreet, Beek Johan F., van der Veen J. P. Wietze, van der Horst Chantal M. A. M., Wolkerstorfer Albert Hypertrophy in port-wine stains: Prevalence and patient characteristics in a large patient cohort Journal of the American Academy of Dermatology 2012;67 (6):1214-1219 [PubMed]
  • Vrijman C., van Drooge A. M., Limpens J., Bos J. D., van der Veen J. P. W., Spuls P. I., Wolkerstorfer A. Laser and intense pulsed light therapy for the treatment of hypertrophic scars: a systematic review British journal of dermatology 2011;165 (5):934-942 [PubMed]
All Publications
Research programmes

Prof. PhD R.M. Luiten (Pigment cell disorders of the skin)

Current research funding
  • AMC
  • Novartis Pharma AG